Catalyst Wire Dossier Catalyst Wire Dossier

PARAGLIDE

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PARAGLIDE, covering 2024-07-29 to 2024-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) [Phase 3]

See pricing